Back to GetFilings.com



Table of Contents

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 


 

FORM 10-Q

 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the quarterly period ended July 31, 2004

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the transition period from                      to                     

 

Commission file number 000-29665

 

EXCELSIOR VENTURE PARTNERS III, LLC

(Exact Name of Registrant as Specified in Its Charter)

 

DELAWARE   13-4102528
(State or Other Jurisdiction of Incorporation or Organization)   (I.R.S. Employer Identification No.)
225 High Ridge Road, Stamford, CT   06905
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, Including Area Code (203) 352-4400

 

114 West 47th Street, New York, NY 10036-1532

Former Name, Former Address and Former Fiscal Year, if Changed Since last Report.

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined by Rule 12b-2 of the Act). Yes ¨ No x

 



Table of Contents

EXCELSIOR VENTURE PARTNERS III, LLC

 

The filing of the Registrant’s report is delayed pending clarification of information recently received by the Registrant from its independent accountants. This information relates to the status of such accountants as “independent” within the meaning of Rule S-X of the Securities and Exchange Commission. Registrant is informed that such accountants are seeking guidance from the accounting staff of the Commission on this issue. Consequently, the Registrant cannot determine that the requirements of Rule S-X applicable to financial statements included in this Report, and possibly certain prior reports, that such statements be reviewed by independent public accountants have been met.

 

This Quarterly Report on Form 10-Q contains historical information and forward-looking statements. Statements looking forward in time are included in this Form 10-Q pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. They involve known and unknown risks and uncertainties that may cause Excelsior Venture Partners III, LLC’s (the “Company’s”) actual results to differ from future performance suggested herein.

 

    

INDEX


   PAGE NO.

PART I.

  

FINANCIAL INFORMATION

    

Item 1.

  

Financial Statements

   1
    

Summarized Portfolios of Investments

   1
    

Portfolios of Investments as of July 31, 2004 and October 31, 2003

   2
    

Statements of Assets and Liabilities at July 31, 2004 and October 31, 2003

   7
    

Statements of Operations for the nine-month periods ended July 31, 2004 and July 31, 2003

   8
    

Statements of Operations for the three-month periods ended July 31, 2004 and July 31, 2003

   9
    

Statements of Changes in Net Assets for the nine-month periods ended July 31, 2004 and July 31, 2003

   10
    

Statements of Cash Flows for the nine-month periods ended July 31, 2004 and July 31, 2003

   11
    

Financial Highlights for the nine-month periods ended July 31, 2004 and July 31, 2003

   12
    

Notes to Financial Statements

   13

Item 2.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

   19

Item 3.

  

Quantitative and Qualitative Disclosures about Market Risk

   21

Item 4.

  

Controls and Procedures

   21

PART II.

  

OTHER INFORMATION

    

Item 1.

  

Legal Proceedings

   21

Item 2.

  

Changes in Securities and Use of Proceeds

   21

Item 3.

  

Defaults Upon Senior Securities

   22

Item 4.

  

Submission of Matters to a Vote of Security Holders

   22

Item 5.

  

Other Information

   22

Item 6.

  

Exhibits and Reports on Form 8-K

   22

 


Table of Contents
PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

Excelsior Venture Partners III, LLC

Summarized Portfolio of Investments (Unaudited)

 

     July 31, 2004

 

PORTFOLIO STRUCTURE


   Value

    Percent of Net
Assets


 

SHORT-TERM INVESTMENTS:

              

AGENCY OBLIGATIONS

   $ 37,553,636     30.57 %

INVESTMENT COMPANIES

     3,673,855     2.99 %

PRIVATE AND PUBLIC COMPANIES

     77,634,663     63.20 %

PRIVATE INVESTMENT FUNDS

     4,729,221     3.85 %
    


 

TOTAL INVESTMENTS

     123,591,375     100.62 %

OTHER ASSETS & LIABILITIES (NET)

     (756,231 )   (0.62 )%
    


 

NET ASSETS

   $ 122,835,144     100.00 %
    


 

 

Excelsior Venture Partners III, LLC

Summarized Portfolio of Investments

 

     October 31, 2003

 

PORTFOLIO STRUCTURE


   Value

   Percent of Net
Assets


 

SHORT-TERM INVESTMENTS:

             

AGENCY OBLIGATIONS

   $ 52,994,406    43.27 %

INVESTMENT COMPANIES

     519,599    0.42 %

PRIVATE COMPANIES

     62,905,542    51.37 %

PRIVATE INVESTMENT FUNDS

     3,080,766    2.52 %
    

  

TOTAL INVESTMENTS

     119,500,313    97.58 %

OTHER ASSETS & LIABILITIES (NET)

     2,957,540    2.42 %
    

  

NET ASSETS

   $ 122,457,853    100.00 %
    

  

 

Notes to Financial Statements are an integral part of these Financial Statements.

 

1


Table of Contents

Excelsior Venture Partners III, LLC

Portfolio of Investments July 31, 2004 (Unaudited)

 

Principal
Amount/Shares


       

Acquisition

Date ##


  

Value

(Note 1)


  AGENCY OBLIGATIONS — 30.57%            
$ 37,560,000    Federal National Mortgage Association, 1.22%, 08/05/04 (Cost $37,553,636)         $ 37,553,636
                

  PUBLIC COMPANIES **, # — 3.69%            
      Common Stocks — 3.69%            
          Consumer Products — 1.47%            
                

              428,572    Senomyx, Inc. *    06/04      1,812,003
                

          Semiconductor — 2.22%            
              384,615    Netlogic Microsystems, Inc. *    07/04      2,721,922
                

       TOTAL PUBLIC COMPANIES (Cost $6,500,000)           4,533,925
                

  PRIVATE COMPANIES **, #, @ — 59.51%            
      Common Stocks — 0.00%            
          Capital Equipment — 0.00%            
              157,396    MIDAS Vision Systems, Inc.    03/03      —  
                

          Life Sciences — 0.00%            
              46,860    Genoptix, Inc.    07/03      —  
                

          Semiconductor — 0.00%            
              708,955    Monterey Design Systems, Inc.    06/03      —  
                    
       TOTAL COMMON STOCKS (Cost $8,749,999)           —  
                

      Preferred Stocks — 56.66%            
          Capital Equipment — 0.00%            
              933,593    MIDAS Vision Systems, Inc., Series A-1    03/03      —  
                

          Consumer Electronics — 3.73%            
              1,523,810    Gyration, Inc., Series C-2    03/03 & 07/04      4,584,054
                

          Enterprise Software — 9.29%            
              19,995,000    ***Datanautics, Inc. Series A Preferred    01/04      4,000,000
              7,454,720    LogicLibrary, Inc., Series A    01/02, 08/03, 05/04      3,408,450
              20,000,000    ***Pilot Software Inc., Series A    05/02 & 04/03      4,000,000
                

                   11,408,450
                

          Information Services — 0.00%            
              4,425    Cenquest, Inc., Series 2    7/01      —  
                

          Life Sciences — 6.30%            
              647,948    Adeza Biomedical Corporation, Series 5    09/01      3,000,000
              1,999,999    Archemix Corporation, Inc., Series A    08/02, 01/03, 11/03      1,999,999
              233,333    Archemix Corporation, Inc., Series B    03/04      233,333
              942,481    Genoptix, Inc., Series B-1    12/01      1,253,500
              1,403,696    Genoptix, Inc., Series B-2    07/03, 09/03, 12/03      1,250,000
                

                   7,736,832
                

          Medical Technology — 5.23%            
              4,166,667    Tensys Medical, Inc., Series C    03/02      5,000,000
              1,187,500    Tensys Medical Inc., Series D    05/04      1,425,000
                

                   6,425,000
          Optical — 11.52%            
              4,330,504    LightConnect, Inc., Series B    07/01      5,000,000
              12,292,441    LightConnect, Inc., Series C    12/02      992,000
              956,234    NanoOpto Corporation, Series A-1    10/01 & 03/02      —  
              3,023,399    NanoOpto Corporation, Series B    09/03, 11/03,
01/04, 07/04
     1,655,118
              5,333,333    OpVista, Inc., Series B    07/01      1,500,000
              12,671,059    OpVista, Inc., Series C    09/03      5,000,000
                

                   14,147,118
          Semiconductor — 15.18%            
  7,000,000    Chips & Systems, Inc., Series A    03/04      3,500,000
  3,333,333    Monterey Design Systems, Inc., Series 2    06/03      5,400,000
                    
  2,211,898    Silverback Systems, Inc., Series B-1    02/02      450,051
  34,364,257    Silverback Systems, Inc., Series C    03/03, 09/03, 04/04      4,298,896
  3,096,551    Virtual Silicon Technology, Inc., Series C    12/01      5,000,000
                

                   18,648,947

 

2


Table of Contents

Excelsior Venture Partners III, LLC

Portfolio of Investments July 31, 2004 (Unaudited) — (continued)

 

Principal
Amount/Shares/

Percent Owned


        Acquisition
Date ##


   Value (Note 1)

 
          PRIVATE COMPANIES **,#,@ (continued)              
  Wireless — 5.41%              
              4,433,333   

Ethertronics, Inc., Series B

   06/01, 09/02, 07/03,
05/04
   $ 6,650,000  
                


      

TOTAL PREFERRED STOCKS (Cost $72,790,187)

          69,600,401  
                


  Notes — 2.28%              
      Consumer Electronics — 2.82%              
$ 2,797,200   

Gyration, Inc., Bridge Note 12%, 6/2/2004

   12/03      3,466,994  
                


      

TOTAL NOTES (Cost $2,797,200)

          3,466,994  
                


  Warrants — 0.03%              
          Consumer Electronics — 0.03%              
  1   

Gyration, Inc.

   12/03      33,343  
                


  Wireless — 0.00%              
  100,000   

Ethertronics, Inc.

   09/02       
  115,000   

Ethertronics, Inc.

   07/03       
  66,667   

Ethertronics, Inc.

   08/03       
                


                    
      

TOTAL WARRANTS (Cost $2,800)

          33,343  
                


      

TOTAL — PRIVATE COMPANIES (Cost $84,340,186)

          73,100,738  
                


  PRIVATE INVESTMENT FUNDS **, # — 3.85%              
  0.39%   

Advanced Technology Ventures VII, LP

   08/01-04/04      684,183  
  1.38%   

Burrill Life Sciences Capital Fund

   12/02-03/04      532,762  
  1.35%   

CHL Medical Partners II, LP

   01/02-02/04      509,860  
  4.94%   

CMEA Ventures Partners, LP

   12/03-04/04      104,573  
  0.36%   

Morgenthaler Partners VII, LP

   07/01-07/04      1,150,473  
  0.59%   

Prospect Venture Partners II, LP

   06/01-07/04      1,105,337  
  2.36%   

Tallwood II, LP

   12/02-06/04      455,128  
  1.75%   

Valhalla Partners II, LP

   10/03-03/04      186,905  
                


      

TOTAL — PRIVATE INVESTMENT FUNDS (Cost $5,787,433)

          4,729,221  
                


  INVESTMENT COMPANIES — 2.99%              
  3,673,855   

Dreyfus Government Cash Management Fund Institutional Shares (Cost $3,673,855)

          3,673,855  
                


  TOTAL INVESTMENTS (Cost $137,855,110) – 100.62%           123,591,375  
  OTHER ASSETS & LIABILITIES (NET) – (0.62)%           (756,231 )
                


  NET ASSETS—100.00%         $ 122,835,144  
                



* Carrying value per unit reflects a 30% discount to the closing price.

 

**<